| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.64 | 0.01 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |